HMS
GBT

Hanseatic Management Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Hanseatic Management Services’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,489
Closed -$178K – 243
2020
Q1 		$178K Buy
+3,489
New +$234K 0.19% 111
2018
Q2 		– Sell
-3,511
Closed -$170K – 492
2018
Q1 		$170K Buy
+3,511
New +$196K 0.16% 125

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Hanseatic Management Services's GBT Position: Q2 2020 in Review

Hanseatic Management Services sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2020, closing a stake of 3,489 shares — an estimated $178K sold.

Hanseatic Management Services first reported a position in GBT in Q1 2018 and held it in 2 quarters. The position peaked at $178K in Q1 2020. 253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

  • Hanseatic Management Services reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Hanseatic Management Services sold 3,489 Global Blood Therapeutics, Inc. shares in Q2 2020, an estimated $178K.
  • Hanseatic Management Services first reported a position in Global Blood Therapeutics, Inc. in Q1 2018 and held it in 2 quarters.
  • Hanseatic Management Services's Global Blood Therapeutics, Inc. position peaked at $178K in Q1 2020.
  • 253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on Hanseatic Management Services's 13F filing for Q2 2020, filed 6 Aug 2020.